Active trials
Read more about the upcoming active trials that MedVadis Research is involved with. Contact us anytime if you would like to volunteer or have any questions.
Adult Migraine
No Results Found.
The page you requested could not be found. Try refining your search, or use the navigation above to locate the post.
ALS
No Results Found.
The page you requested could not be found. Try refining your search, or use the navigation above to locate the post.
Alzheimer’s Disease
No Results Found.
The page you requested could not be found. Try refining your search, or use the navigation above to locate the post.
Chronic Low Back Pain
Study ID 236
A Master Protocol for Randomized, Placebo-Controlled, Phase 2 Clinical Trials of Multiple Interventions for the Treatment of Chronic Pain
The purpose of the chronic pain master protocol is to compare independent pain interventions and establish an overarching structure for the disease-state addenda (DSA) and intervention-specific appendices (ISAs). The ISAs may start independently of other ISAs as interventions become available for clinical testing.
Medical Conditions:
Chronic Back Pain
Related Conditions: Chronic Back Pain
Sex/Gender: Male & Female
Age: 18 Years and Older
Enrolling Soon!
Diabetic Neuropathy
No Results Found.
The page you requested could not be found. Try refining your search, or use the navigation above to locate the post.
Obesity
Study ID 305
A Phase 3 Study to Investigate the Efficacy and Safety of Orforglipron Once Daily in Participants Who Have Obesity or Overweight and Osteoarthritis of the Knee: A Multicenter, Randomized, Double-Blind, Parallel-Arm, Placebo-Controlled Trial (ATTAIN-OA PAIN)
The GZPT master protocol will support two independent studies, J2A-MC-GZT1 and J2A-MC-GZT2. Each study will see how well and safely orforglipron works in people with obesity or overweight who have osteoarthritis (OA) of the knee with pain. Participation in the study will last about 74 weeks.
Medical Conditions:
Obesity
Related Conditions: Obesity
Sex/Gender: Male & Female
Age: 18 Years and Older
Enrolling Soon!
Gout
Study ID 303
A Phase 3, Randomized, Double-Blind, Multicenter Study to Evaluate the Efficacy and Safety of Dotinurad Compared With Allopurinol in Adult Participants With Hyperuricemia Associated With Gout
The primary objective of this study is to evaluate the efficacy of dotinurad in lowering serum uric acid (sUA) at Week 24 compared with allopurinol in adult participants with hyperuricemia associated with gout.
Medical Conditions:
Gout
Related Conditions: Gout
Sex/Gender: Male & Female
Age: 18 Years to 75 Years
Enrolling Soon!
Study ID 304
A Phase 3, Randomized, Double-Blind, Multicenter Study to Evaluate the Efficacy and Safety of Dotinurad Compared With Allopurinol in Adult Participants With Tophaceous Gout
The primary objective of this study is to evaluate the efficacy of dotinurad in lowering serum uric acid (sUA) at Week 24 compared with allopurinol in adult participants with tophaceous gout.
Medical Conditions:
Gout
Related Conditions: Gout
Sex/Gender: Male & Female
Age: 18 Years to 75 Years
Enrolling Soon!
Chronic Knee Pain
Study ID 305
A Phase 3 Study to Investigate the Efficacy and Safety of Orforglipron Once Daily in Participants Who Have Obesity or Overweight and Osteoarthritis of the Knee: A Multicenter, Randomized, Double-Blind, Parallel-Arm, Placebo-Controlled Trial (ATTAIN-OA PAIN)
The GZPT master protocol will support two independent studies, J2A-MC-GZT1 and J2A-MC-GZT2. Each study will see how well and safely orforglipron works in people with obesity or overweight who have osteoarthritis (OA) of the knee with pain. Participation in the study will last about 74 weeks.
Medical Conditions:
Chronic Knee Pain
Related Conditions: Chronic Knee Pain
Sex/Gender: Male & Female
Age: 18 Years and Older
Enrolling Soon!
Study ID 236
A Master Protocol for Randomized, Placebo-Controlled, Phase 2 Clinical Trials of Multiple Interventions for the Treatment of Chronic Pain
The purpose of the chronic pain master protocol is to compare independent pain interventions and establish an overarching structure for the disease-state addenda (DSA) and intervention-specific appendices (ISAs). The ISAs may start independently of other ISAs as interventions become available for clinical testing.
Medical Conditions:
Chronic Knee Pain
Related Conditions: Chronic Knee Pain
Sex/Gender: Male & Female
Age: 18 Years and Older
Enrolling Soon!